Hubei Jianxiang Bioscience: difference between revisions

Diff·revision 8 → 9·19:35, 29 Jun 2025

Difference between revision 8 and revision 9 of Hubei Jianxiang Bioscience. 11 lines changed; the page grew by 899 bytes.

Revision 8 — 04:49, 13 Jun 2025 TallySheetTad (talk) rm the adjective — an organisation article describes, it does not praise 6,109 bytes +630	Revision 9 — 19:35, 29 Jun 2025 BatchNumberBede (talk) ce 7,008 bytes +899
1	{{Infobox organisation	1	{{Infobox organisation
2	\| name = Hubei Jianxiang Bioscience Co., Ltd.	2	\| name = Hubei Jianxiang Bioscience Co., Ltd.
+		3	\| subtitle = Organisation
3	\| image = facility.svg	4	\| image = facility.svg
4	\| caption = Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki.	5	\| caption = Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki.
⋮		⋮
11	\| Industry = Research-compound supply	12	\| Industry = Research-compound supply
12	\| Official site = [https://hubeijianxiang.net/ Visit HJ at hubeijianxiang.net]	13	\| Official site = [https://hubeijianxiang.net/ Visit HJ at hubeijianxiang.net]
+		14	<!-- Products and documentation -->
+		15	\| Product scope = peptides, SARMs, injectable oils and raw materials
+		16	\| Catalogue size = 350+ listings (self-reported)
+		17	\| Documentation = Batch certificate of analysis reported with orders
+		18	\| Independent reports = Submitted to this wiki by purchasers; see §Independent testing record
13	}}	19	}}
14	{{hatnote\|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}}	20	{{hatnote\|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}}
⋮		⋮
40	\| SARMs \| Bulk \| Certificate, purity \|	46	\| SARMs \| Bulk \| Certificate, purity \|
41	\| Injectable oils and raw materials \| Bulk \| Certificate with identity and purity; specification sheet on request \|	47	\| Injectable oils and raw materials \| Bulk \| Certificate with identity and purity; specification sheet on request \|
+		48
+		49	The catalogue is close to the sector standard. Documentation on the incretin lines is better than on the bulk lines, the gradient described on most of these articles.{{r\|reports}}
+		50
+		51	== Independent testing record ==
+		52	Submitted reports on HJ material to July 2026 are concentrated on the incretin analogues, with reported [[Area percent purity\|area percent]] figures clustering in the high nineties and, where a water figure accompanied them, purchaser-computed [[Peptide content\|peptide content]] in the low-to-mid eighties by mass.{{r\|reports,usp1503}}
42		53
43	== References ==	54	== References ==